|
3rd International Conference on Hypertension, Lipids, Diabetes and Stroke Prevention will address important issues, regarding stroke prevention and stroke risk reduction including Hypertension, Dyslipidemia, HDL, Diabetic and Metabolic Syndromes and therapeutic interventions, for reducing Stroke. The conference program will feature pre-conference satellite symposium, plenary sessions, key note lectures and comprehensive conversation opportunity. The conference will provide a special opportunity to network with associates and exchange notions, in an affable atmosphere. The attendees will find ample opportunities to talk about the up-to-date advances and discuss with the professionals.
The conference program will discuss the following key topics:
- Hypertension and Risk of Stroke
- Dyslipidemia and Risk of Stroke
- HDL and Risk of Stroke
- Statins and Stroke Risk Reduction
- ACE, ARBS and CCBS in Stroke Prevention
- Emerging Biomarkers of Stroke
- PPAR Alpha Agonists and ACAT-Inhibitors and Stroke
- Carotid Atherosclerosis (IMT) as a Surrogate Endpoint for Therapeutic Intervention
- Stroke Prevention and Vascular Dementia
- Endocanabinoid Receptor Blocker
- Diabetic, Metabolic Syndrome and Stroke Prevention
- Therapeutic Intervention to Reduce Stroke
- Risk Factor and Vascular Cognitive Impairment
Visitor Profile
Targeted visitors at 3rd International Conference on Hypertension, Lipids, Diabetes and Stroke Prevention are:
- Scientists
- Doctors
- Researchers
- Practitioners
- Related Professionals
Organizer
Kenes International